Skip to main content

Table 1 Baseline characteristics

From: A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial

 

30 µg R0.6C/AlOH

30 µg R0.6C/AlOH + Matrix-M

100 µg R0.6C/AlOH

100 µg R0.6C/AlOH + Matrix-M

Participants (n)

8

8

8

8

Female/male (n)

5/3

4/3

6/2

6/2

Age (years)

23 (18–51)

25 (19–53)

22 (20–47)

22 (18–49)

Weight (kg)

73.5 (57.0–90.0)

73.7 (61.0–75.6)

68.4 (57.8–89.0)

65.0 (57.0–72.8)

BMI (kg/m2)

24.2 (20.8–28.8)

22.2 (18.7–27.4)

23.1 (19.5–29.3)

22.6 (19.2–24.6)

  1. Median values for age, weight and BMI at baseline are shown with the full range in brackets